What is Cohort?
Indication and Elements of Cohort Study.
What is Relative risk and Attributable risk, and its interpretation?
Advantages & disadvantages of Cohort study.
Difference between Case control & Cohort study.
Sensitivity, specificity and likelihood ratiosChew Keng Sheng
A short tutorial on sensitivity, specificity and likelihood ratios. In this presentation, I demonstrate why likelihood ratios are better parameters compared to sensitivity and specificity in real world setting.
What is Cohort?
Indication and Elements of Cohort Study.
What is Relative risk and Attributable risk, and its interpretation?
Advantages & disadvantages of Cohort study.
Difference between Case control & Cohort study.
Sensitivity, specificity and likelihood ratiosChew Keng Sheng
A short tutorial on sensitivity, specificity and likelihood ratios. In this presentation, I demonstrate why likelihood ratios are better parameters compared to sensitivity and specificity in real world setting.
Ethical considerations in Clinical Research Dr Ankita.pptxClinosolIndia
Ethical considerations are paramount in clinical research to protect the rights, well-being, and confidentiality of participants, as well as to ensure data integrity and maintain public trust. Here are some key ethical considerations in clinical research:
Informed Consent: Obtaining informed consent from participants is crucial. Participants should receive clear, understandable information about the study purpose, procedures, potential risks and benefits, alternatives, confidentiality measures, and their right to withdraw at any time. Informed consent should be voluntary, free from coercion, and obtained prior to participation.
Institutional Review Board (IRB) Approval: All clinical research involving human participants must undergo review by an independent IRB or ethics committee. The IRB evaluates the study's ethical implications, participant protections, study design, and informed consent process to ensure that the benefits of the research outweigh the potential risks.
Participant Safety and Monitoring: Safeguarding participant safety is paramount. Researchers should monitor participants closely, promptly address any adverse events or risks, and have protocols in place for participant safety and medical care. Regular safety monitoring and data analysis should be conducted throughout the study.
Data Privacy and Confidentiality: Protecting participant privacy and ensuring data confidentiality are critical. Researchers must adhere to applicable data protection regulations and establish robust measures to safeguard participant data, including de-identification, encryption, secure data storage, and restricted access. Only authorized personnel should have access to identifiable participant information.
Data Integrity and Transparency: Maintaining data integrity is essential for reliable research outcomes. Researchers should accurately collect, record, and report data, adhering to Good Clinical Practice (GCP) guidelines. Data should be analyzed objectively and reported transparently, avoiding any selective or biased reporting that could compromise the scientific integrity of the study.
Equity and Fairness: Clinical research should be conducted in a manner that promotes equity and fairness. Participants should be recruited and selected based on scientifically justified criteria, without discrimination or bias. Efforts should be made to ensure diverse representation in research studies to avoid underrepresentation of certain populations.
Post-trial Access: Participants should have the opportunity to access the study intervention or any relevant follow-up care once the trial is completed, particularly if the intervention has demonstrated significant benefit. Researchers should consider post-trial access in the study design and communicate the availability of such access to participants during the informed consent process.
Clinical Research Statistics for Non-StatisticiansBrook White, PMP
Through real-world examples, this presentation teaches strategies for choosing appropriate outcome measures, methods for analysis and randomization, and sample sizes as well as tips for collecting the right data to answer your scientific questions.
Case-control study is a variety of analytical studies. This is a brief presentation regarding history, design, issues, advantages - disadvantages and examples of Case-control study.
In clinical trials and other scientific studies, an interim analysis is an analysis of data that is conducted before data collection has been completed. If a treatment is particularly beneficial or harmful compared to the concurrent placebo group while the study is on-going, the investigators are ethically obliged to assess that difference using the data at hand and to make a deliberate consideration of terminating the study earlier than planned.
In interim analysis, whenever a new drug shows adverse effect on human being while testing the effectiveness of several drugs, we immediately stop the trial by taking into account the fact that maximum number of patients receive most effective treatment at the earliest stage. Interim analysis is also used to possibly reduce the expected number of patients and to shorten the follow-up time needed to make a conclusion. One wouldn't have to spend extra money if he/she already have enough evidence about the outcome. In this presentation, the total sample size is divided into four equal parts to perform the analysis and decision is made based on each individual step.
Ethical considerations in Clinical Research Dr Ankita.pptxClinosolIndia
Ethical considerations are paramount in clinical research to protect the rights, well-being, and confidentiality of participants, as well as to ensure data integrity and maintain public trust. Here are some key ethical considerations in clinical research:
Informed Consent: Obtaining informed consent from participants is crucial. Participants should receive clear, understandable information about the study purpose, procedures, potential risks and benefits, alternatives, confidentiality measures, and their right to withdraw at any time. Informed consent should be voluntary, free from coercion, and obtained prior to participation.
Institutional Review Board (IRB) Approval: All clinical research involving human participants must undergo review by an independent IRB or ethics committee. The IRB evaluates the study's ethical implications, participant protections, study design, and informed consent process to ensure that the benefits of the research outweigh the potential risks.
Participant Safety and Monitoring: Safeguarding participant safety is paramount. Researchers should monitor participants closely, promptly address any adverse events or risks, and have protocols in place for participant safety and medical care. Regular safety monitoring and data analysis should be conducted throughout the study.
Data Privacy and Confidentiality: Protecting participant privacy and ensuring data confidentiality are critical. Researchers must adhere to applicable data protection regulations and establish robust measures to safeguard participant data, including de-identification, encryption, secure data storage, and restricted access. Only authorized personnel should have access to identifiable participant information.
Data Integrity and Transparency: Maintaining data integrity is essential for reliable research outcomes. Researchers should accurately collect, record, and report data, adhering to Good Clinical Practice (GCP) guidelines. Data should be analyzed objectively and reported transparently, avoiding any selective or biased reporting that could compromise the scientific integrity of the study.
Equity and Fairness: Clinical research should be conducted in a manner that promotes equity and fairness. Participants should be recruited and selected based on scientifically justified criteria, without discrimination or bias. Efforts should be made to ensure diverse representation in research studies to avoid underrepresentation of certain populations.
Post-trial Access: Participants should have the opportunity to access the study intervention or any relevant follow-up care once the trial is completed, particularly if the intervention has demonstrated significant benefit. Researchers should consider post-trial access in the study design and communicate the availability of such access to participants during the informed consent process.
Clinical Research Statistics for Non-StatisticiansBrook White, PMP
Through real-world examples, this presentation teaches strategies for choosing appropriate outcome measures, methods for analysis and randomization, and sample sizes as well as tips for collecting the right data to answer your scientific questions.
Case-control study is a variety of analytical studies. This is a brief presentation regarding history, design, issues, advantages - disadvantages and examples of Case-control study.
In clinical trials and other scientific studies, an interim analysis is an analysis of data that is conducted before data collection has been completed. If a treatment is particularly beneficial or harmful compared to the concurrent placebo group while the study is on-going, the investigators are ethically obliged to assess that difference using the data at hand and to make a deliberate consideration of terminating the study earlier than planned.
In interim analysis, whenever a new drug shows adverse effect on human being while testing the effectiveness of several drugs, we immediately stop the trial by taking into account the fact that maximum number of patients receive most effective treatment at the earliest stage. Interim analysis is also used to possibly reduce the expected number of patients and to shorten the follow-up time needed to make a conclusion. One wouldn't have to spend extra money if he/she already have enough evidence about the outcome. In this presentation, the total sample size is divided into four equal parts to perform the analysis and decision is made based on each individual step.
Excelsior College PBH 321 Page 1 EXPERI MENTAL E.docxgitagrimston
Excelsior College PBH 321
Page 1
EXPERI MENTAL E PIDE MIOLOGICAL STUDIE S
Epidemiologic studies are either observational or experimental. Observational studies, including ecologic,
cross-sectional, cohort, and case-control designs, are considered “natural” experiments, but experimental
studies are considered true experiments. We will spend the next 2 modules discussing these designs.
Before we begin to discuss study designs, we need a brief introduction to a concept that we will spend more
time discussing in later modules -- bias. The definition of bias is:
“Deviation of results or inferences from the truth, or processes leading to such deviation. Any trend in the
collection, analysis, interpretation, publication, or review of data that can lead to conclusions that are
systematically different from the truth.” (Last, J.M., A Dictionary of Epidemiology, 4th ed.)
Epidemiologists are naturally concerned whether the results of an epidemiologic study are biased, since many
important public health decisions are often drawn from epidemiologic research. The severity of the bias, that
is - how much it influences or distorts the results, is related to the study design as well as how information is
analyzed.
Experimental Studies
The defining feature of experimental studies is that the investigator assigns exposure to the study subjects.
Experimental studies most closely resemble controlled laboratory experiments and serve as models for the
conduct of observational studies, thus they are the “gold standard” of epidemiologic research. Experimental
studies have high validity (i.e., less bias), and can identify even very small effects. The most well known type of
experimental study is a randomized trial (sometimes referred to as a randomized controlled trial), where the
investigator randomly assigns exposure to the study subjects. In this type of study, the only expected
difference between the experimental and control groups is the outcome variable being studied.
Experimental designs like the randomized trial can assess both preventive interventions, where a prophylactic
agent is given to healthy or high-risk individual to prevent disease, or can assess effects of therapeutic
treatment, such as those given to diseased individuals to reduce their risk of disease recurrence, or to improve
their survival or quality of life.
Preventive intervention: Does tamoxifen lower the incidence of breast cancer in women with high risk profile
compared to high risk women not given tamoxifen?
Therapeutic intervention: Do combinations of two or three antiretroviral drugs prolong survival of AIDS
patients as well as regimens of single drugs?
The investigator can assign exposures (or allocate interventions) to either individuals or to an entire
community.
Individual-level assignment: Do women with stage I breast cancer given a lumpectomy alone survive as long
without recurrence of disease as women given a lumpec ...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
2. Outline
Overview
Steps in conducting a cohort study
Advantages
Disadvantages
Potential sources of bias
3.
4. Overview
Also referred to as Prospective, Incidence, Longitudinal
or Follow up studies
Exposure status is determined amongst a group of
persons sharing the same experience (cohorts) followed
for a specified period of time to determine the incidence
of a disease or event (outcome)
Comparison of incidences to test causative/protective
hypothesis
Example:
Framingham Study: Risk factors in 30 -62 yr old
residents(cohorts) CHD (Outcome)
Dolls: In Physicians of same age group (Cohorts)
Smoking (Exposure) Lung cancer (Outcome)
7. StepsinaCohort
Study:
Selection ofstudy
population
Depends on:
Frequency of exposures of interest
for exposures common among the general population -
the general population
Groups of individuals with special/unusual exposures.
E.g. occupational hazards, Folic acid supplementation in
pregnancy
Need complete and accurate exposure and follow-up
information
8. StepsinaCohort
Study:
Selection of
Exposed/Unexpos
edgroups
Clear definition
The definition must include the following:
The minimal acceptable levels of exposure
The minimal duration of exposure
Other eligibility criteria like age, sex, absence or
presence of pre-existing medical conditions
the exclusion criteria must include the absence of the
outcome of interest
Data may be collected from pre-existing records,
directly from interviewing the subjects, measurements
etc.
9. StepsinaCohort
Study:
Determining
Outcome
Present/Absent
Groups
Duration of follow-up to determine outcome dependent
on disease latency period
Clear definition - process of establishing outcome must
be clearly stated
Data may be collected from Routine surveillance data,
Death certificates, Examination of the cohorts, Records
etc.
10.
11. Advantagesof
CohortStudies
Measures incidence
Gives a direct measurement of risk
Dose effect can be determined
Temporal relationship between exposure & disease is
clear
Minimizes selection and information bias (especially
Prospective cohort studies)
Well suited to rare exposures
Several outcomes can be examined in one study
12. Disadvantages
ofCohort
Studies
Often requires large sample size
Latency period: long follow-up period or bias
Attrition - loss to follow-up can affect validity of
findings
Exposure can change over time
Ineffective for rare diseases
Difficult to assess multiple exposures
Time consuming and expensive
Some problems of bias may occur
Ethical issues
13. PotentialBiases
inCohort
Studies
Selection bias
– loss to follow-up
Information bias
– from different quality and extent of
information obtained
apply the same protocol for measuring or evaluating the
health outcomes in exposed and nonexposed individuals
Blinding
The cohorts are similar in all other experiences/factors except the exposure of interest.
Open/Dynamic cohort – is one where people can enter or leave. Examples: A workforce study that is ongoing, A city or other geographic location. A closed cohort is where all persons in the cohort are defined at entry e.g UI medical school class of 2004
Special group exposures: exposure to aniline (dye factory workers), Use of PPE or not (health workers)
For accurate information, purposely selecting groups likely to give accurate and complete information or groups that have available record of the exposure
RR=1 No association
RR>1 Risk of outcome increased with exposure (causative)
RR<1 Risk of outcome decreased (protective factor)
Information bias: mostly from ‘over-searching’ for outcome in exposed
Prevented by applying same protocol for both groups and by masking exposure status from the person who decides presence or absence of outcome
Health worker effect
Hawthorne effect – exposed changing to unexposed withou